Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4Q734
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003723 | RNA binding | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.587 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.613 |
CLV_PCSK_PC1ET2_1 | 150 | 152 | PF00082 | 0.457 |
CLV_PCSK_PC1ET2_1 | 33 | 35 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 143 | 147 | PF00082 | 0.253 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.253 |
DOC_PP1_RVXF_1 | 91 | 97 | PF00149 | 0.453 |
DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.623 |
DOC_USP7_UBL2_3 | 146 | 150 | PF12436 | 0.445 |
DOC_WD40_RPTOR_TOS_1 | 19 | 24 | PF00400 | 0.480 |
LIG_14-3-3_CanoR_1 | 104 | 108 | PF00244 | 0.470 |
LIG_14-3-3_CanoR_1 | 86 | 94 | PF00244 | 0.460 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.634 |
LIG_BRCT_BRCA1_1 | 192 | 196 | PF00533 | 0.620 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.493 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.453 |
LIG_IBAR_NPY_1 | 197 | 199 | PF08397 | 0.649 |
LIG_LIR_Gen_1 | 118 | 126 | PF02991 | 0.556 |
LIG_LIR_Nem_3 | 118 | 123 | PF02991 | 0.539 |
LIG_LIR_Nem_3 | 193 | 199 | PF02991 | 0.647 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.463 |
LIG_SUMO_SIM_anti_2 | 103 | 110 | PF11976 | 0.545 |
LIG_TRAF2_1 | 38 | 41 | PF00917 | 0.520 |
LIG_TRAF2_1 | 47 | 50 | PF00917 | 0.474 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.527 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.514 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.683 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.634 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.531 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.603 |
MOD_N-GLC_1 | 74 | 79 | PF02516 | 0.402 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.573 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.499 |
MOD_PIKK_1 | 190 | 196 | PF00454 | 0.637 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.399 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.550 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.468 |
MOD_Plk_1 | 74 | 80 | PF00069 | 0.396 |
MOD_Plk_2-3 | 17 | 23 | PF00069 | 0.576 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.453 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.396 |
MOD_SUMO_for_1 | 53 | 56 | PF00179 | 0.646 |
TRG_ENDOCYTIC_2 | 120 | 123 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 169 | 172 | PF00400 | 0.637 |
TRG_Pf-PMV_PEXEL_1 | 46 | 50 | PF00026 | 0.526 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I450 | Leptomonas seymouri | 76% | 100% |
A0A0S4JLX4 | Bodo saltans | 51% | 94% |
A0A1X0P1L3 | Trypanosomatidae | 62% | 100% |
A0A3Q8IJK6 | Leishmania donovani | 97% | 100% |
A4HIJ2 | Leishmania braziliensis | 90% | 100% |
A4I5T6 | Leishmania infantum | 97% | 100% |
A6NDY0 | Homo sapiens | 31% | 78% |
B0BNE4 | Rattus norvegicus | 35% | 80% |
E9B131 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q28ZX3 | Drosophila pseudoobscura pseudoobscura | 33% | 96% |
Q54ZS8 | Dictyostelium discoideum | 28% | 97% |
Q5XFR0 | Mus musculus | 31% | 79% |
Q7KNF2 | Drosophila melanogaster | 32% | 96% |
Q93VI4 | Arabidopsis thaliana | 34% | 95% |
Q9FJN9 | Arabidopsis thaliana | 33% | 98% |
V5B7C6 | Trypanosoma cruzi | 60% | 94% |